Collegium Pharmaceutical Inc (COLL)
41.86
+1.97
(+4.94%)
USD |
NASDAQ |
Oct 04, 16:00
41.92
+0.06
(+0.14%)
After-Hours: 20:00
Collegium Pharmaceutical Shareholders Equity (Annual): 195.43M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 195.43M |
| December 31, 2022 | 194.84M |
| December 31, 2021 | 202.93M |
| December 31, 2020 | 186.03M |
| December 31, 2019 | 87.43M |
| December 31, 2018 | 91.58M |
| Date | Value |
|---|---|
| December 31, 2017 | 104.08M |
| December 31, 2016 | 134.91M |
| December 31, 2015 | 85.07M |
| December 31, 2014 | -12.24M |
| December 31, 2013 | 5.582M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
87.43M
Minimum
2019
202.93M
Maximum
2021
173.33M
Average
194.84M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Rigel Pharmaceuticals Inc | -28.64M |
| Esperion Therapeutics Inc | -454.99M |
| Context Therapeutics Inc | 11.87M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |